DelSiTech announces positive topline clinical data from phase 1 trial with its sustained release eye drop platform
/PRNewswire/ -- Drug delivery and development company DelSiTech today reported positive topline results from its Phase 1 clinical trial, evaluating the safety...
Source: prnewswire.com